{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T21:04:55Z","timestamp":1769202295644,"version":"3.49.0"},"reference-count":41,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,9,1]]},"DOI":"10.1210\/jc.2001-020243","type":"journal-article","created":{"date-parts":[[2002,9,5]],"date-time":"2002-09-05T13:22:39Z","timestamp":1031232159000},"page":"4111-4116","source":"Crossref","is-referenced-by-count":80,"title":["Treatment of Central Precocious Puberty by Subcutaneous Injections of Leuprorelin 3-Month Depot (11.25 mg)"],"prefix":"10.1210","volume":"87","author":[{"given":"Jean-Claude","family":"Carel","sequence":"first","affiliation":[{"name":"Groupe Hospitalier Cochin-Saint Vincent de Paul (J.-C.C., O.J., C.T., J.L.C.), Faculte\u0301 Cochin\u2014Universite\u0301 Paris V and Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale U342, Paris 75014, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najiba","family":"Lahlou","sequence":"additional","affiliation":[{"name":"Laboratory of Hormonal Biochemistry (N.L.), Groupe Hospitalier Cochin-Saint Vincent de Paul, Paris 75014, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orlando","family":"Jaramillo","sequence":"additional","affiliation":[{"name":"Groupe Hospitalier Cochin-Saint Vincent de Paul (J.-C.C., O.J., C.T., J.L.C.), Faculte\u0301 Cochin\u2014Universite\u0301 Paris V and Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale U342, Paris 75014, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Montauban","sequence":"additional","affiliation":[{"name":"Takeda Laboratories (V.M., C.L.), Puteaux 92800, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ce\u0301cile","family":"Teinturier","sequence":"additional","affiliation":[{"name":"Groupe Hospitalier Cochin-Saint Vincent de Paul (J.-C.C., O.J., C.T., J.L.C.), Faculte\u0301 Cochin\u2014Universite\u0301 Paris V and Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale U342, Paris 75014, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Colle","sequence":"additional","affiliation":[{"name":"Centre d\u2019Endocrinologie\u2014Pe\u0301diatrique (M.C.), Bordeaux 33000, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christel","family":"Lucas","sequence":"additional","affiliation":[{"name":"Takeda Laboratories (V.M., C.L.), Puteaux 92800, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":", the French Leuprorelin Trial Group,","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Louis","family":"Chaussain","sequence":"additional","affiliation":[{"name":"Groupe Hospitalier Cochin-Saint Vincent de Paul (J.-C.C., O.J., C.T., J.L.C.), Faculte\u0301 Cochin\u2014Universite\u0301 Paris V and Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale U342, Paris 75014, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2019041121510001500_R1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1210\/jcem-71-4-785","article-title":"Clinical review 14: pathophysiology and treatment of sexual precocity.","volume":"71","author":"Kaplan","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121510001500_R2","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM198311243092104","article-title":"Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone.","volume":"309","author":"Mansfield","year":"1983","journal-title":"N Engl J Med"},{"key":"2019041121510001500_R3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/BF02467352","article-title":"Treatment of central precocious puberty with an intranasal analogue of GnRH (Buserelin).","volume":"146","author":"Bourguignon","year":"1987","journal-title":"Eur J Pediatr"},{"key":"2019041121510001500_R4","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1210\/jcem-62-4-670","article-title":"Long term treatment of male and female precocious puberty by periodic administration of long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.","volume":"62","author":"Roger","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121510001500_R5","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1210\/jcem-69-5-1087","article-title":"Suppression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (leuprolide acetate, Lupron depot) in children with precocious puberty.","volume":"69","author":"Kappy","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121510001500_R6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1507\/endocrj1954.38.369","article-title":"A dose finding study of a super long-acting luteinizing hormone-releasing hormone analog (Leuprolide acetate depot, TAP-144-SR) in the treatment of central precocious puberty.","volume":"38","author":"Tanaka","year":"1991","journal-title":"Endocrinol Jpn"},{"key":"2019041121510001500_R7","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1530\/eje.0.1320699","article-title":"Treatment of central precocious puberty with depot leuprolide acetate.","volume":"132","author":"Carel","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"2019041121510001500_R8","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1210\/jcem-69-3-689","article-title":"Depot leuprolide acetate for treatment of precocious puberty.","volume":"69","author":"Parker","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121510001500_R9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1210\/jcem-73-1-50","article-title":"Depot leuprolide acetate dosage for sexual precocity.","volume":"73","author":"Parker","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121510001500_R10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0022-3476(05)81162-X","article-title":"Two-year results of treatment with depot leuprolide acetate for central precocious puberty.","volume":"121","author":"Neely","year":"1992","journal-title":"J Pediatr"},{"key":"2019041121510001500_R11","first-page":"664","article-title":"The effect of luteinizing hormone-releasing hormone analog for central precocious puberty on growth hormone (GH) and GH-binding protein.","volume":"78","author":"DiMartino-Nardi","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121510001500_R12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0022-3476(89)80806-6","article-title":"Leuprolide Study Group. Effects of leuprolide in the treatment of central precocious puberty.","volume":"114","author":"Lee","year":"1989","journal-title":"J Pediatr"},{"key":"2019041121510001500_R13","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1210\/jcem.84.6.5647","article-title":"Final height after long-term treatment with triptorelin slow-release for central precocious puberty: importance of statural growth after interruption of treatment.","volume":"84","author":"Carel","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121510001500_R14","first-page":"4583","article-title":"Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function.","volume":"84","author":"Heger","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121510001500_R15","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1210\/jcem.86.10.7915","article-title":"Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience.","volume":"86","author":"Klein","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121510001500_R16","first-page":"546","article-title":"Long term effect of gonadotropin-releasing hormone agonist therapy in children with true precocious puberty treated at a median age of less than 5 years.","volume":"80","author":"Paul","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121510001500_R17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00008480-200008000-00020","article-title":"Management of central isosexual precocity: diagnosis, treatment, outcome.","volume":"12","author":"Lebrethon","year":"2000","journal-title":"Curr Opin Pediatr"},{"key":"2019041121510001500_R18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0169-409X(97)00050-1","article-title":"One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate.","volume":"28","author":"Okada","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"2019041121510001500_R19","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1023\/A:1018936815654","article-title":"Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers.","volume":"11","author":"Okada","year":"1994","journal-title":"Pharm Res"},{"key":"2019041121510001500_R20","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1023\/A:1018905403359","article-title":"Sustained suppression of the pituitary-gondadal axis by leuprorelin three-month depot microspheres in rats and dogs.","volume":"11","author":"Okada","year":"1994","journal-title":"Pharm Res"},{"key":"2019041121510001500_R21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0169-409X(97)00054-9","article-title":"Therapeutic effects of leuprorelin microspheres in prostate cancer.","volume":"28","author":"Lee","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"2019041121510001500_R22","first-page":"346","article-title":"Gonadotropin-releasing hormone testing in pediatrics","author":"Roger","year":"1996","journal-title":"In: Ranke MB, ed. Diagnostics of endocrine function in children and adolescents. Heidelberg: Johann Ambrosius Barth Verlag;"},{"key":"2019041121510001500_R23","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jcem-65-5-946","article-title":"Gonadotropin and \u03b1-subunit secretion during long-term pituitary suppression by d-Trp6-luteinizing hormone-releasing hormone microcapsule as treatment of precocious puberty.","volume":"65","author":"Lahlou","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121510001500_R24","volume-title":"Auxologie, me\u0301hodes et se\u0301quences","author":"Sempe\u0301","year":"1979"},{"key":"2019041121510001500_R25","doi-asserted-by":"crossref","DOI":"10.1097\/00000441-195909000-00030","volume-title":"Radiographic atlas of skeletal development of the hand and wrist","author":"Greulich","year":"1959"},{"key":"2019041121510001500_R26","volume-title":"SAS user\u2019s guide statistics","year":"1990"},{"issue":"Suppl 1","key":"2019041121510001500_R27","first-page":"723","article-title":"Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics","volume":"13","author":"Lahlou","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"Suppl 2","key":"2019041121510001500_R28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/humrep\/8.suppl_2.29","article-title":"Regulation of gonadotrophin subunit gene expression","volume":"8","author":"Clayton","year":"1993","journal-title":"Hum Reprod"},{"key":"2019041121510001500_R29","first-page":"139","article-title":"Treatment of central precocious puberty with depot Lupron","author":"Lee","year":"1993","journal-title":"In: Grave GD, Cutler GB, eds. Sexual precocity: etiology, diagnosis and management. New York: Raven Press Ltd.;"},{"key":"2019041121510001500_R30","first-page":"653","article-title":"Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.","volume":"147","author":"Clemons","year":"1993","journal-title":"Am J Dis Child"},{"key":"2019041121510001500_R31","first-page":"130","article-title":"Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women.","volume":"77","author":"Filicori","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121510001500_R32","first-page":"2","article-title":"Pharmacocine\u0301tique de la leuprore\u0301line retard et freinage gonadotrope chez des patients traite\u0301s pour cancer de la prostate.","volume":"7","author":"Lahlou","year":"1993","journal-title":"La Lettre du Pharmacologue"},{"issue":"Suppl 1","key":"2019041121510001500_R33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000474238","article-title":"Randomized open labelled comparative study of the efficacy, safety and tolerability of leuprorelin acetate 1M and 3M depot in patients with advanced prostatic cancer","volume":"30","author":"Wechsel","year":"1996","journal-title":"Eur Urol"},{"key":"2019041121510001500_R34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000030200","article-title":"An evaluation of pharmacokinetics and pharmacodynamics of leuprorelin acetate 3M-depot in patients with advanced and metastatic carcinoma of the prostate.","volume":"60","author":"Khan","year":"1998","journal-title":"Urol Int"},{"key":"2019041121510001500_R35","first-page":"246","article-title":"Effectiveness and tolerance of three month sustained release leuprorelin in the treatment of metastatic prostatic cancer (comparative, randomized, multicentric study).","volume":"7","author":"Zerbib","year":"1997","journal-title":"Prog Urol"},{"issue":"Suppl 1","key":"2019041121510001500_R36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000056540","article-title":"Comparison of LH-RH analogue 1-month depot and 3-month depot by their hormone levels and pharmacokinetic profile in patients with advanced prostate cancer","volume":"60","author":"Tunn","year":"1998","journal-title":"Urol Int"},{"key":"2019041121510001500_R37","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1093\/oxfordjournals.humrep.a019199","article-title":"Leuprolide in a 3-monthly versus a monthly depot formulation for the treatment of symptomatic endometriosis: a pilot study.","volume":"11","author":"Crosignani","year":"1996","journal-title":"Hum Reprod"},{"key":"2019041121510001500_R38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s002800050924","article-title":"Endocrinological and clinical evaluation of two depot formulations of leuprolide acetate in pre- and perimenopausal breast cancer patients.","volume":"43","author":"Boccardo","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"key":"2019041121510001500_R39","first-page":"61","article-title":"Long-term therapy of children with true precocious puberty with three GnRH agonists administered by different modes","author":"Kaplan","year":"1993","journal-title":"In: Grave GD, Cutler GB, eds. Sexual precocity: etiology, diagnosis and treatment. New York: Raven Press Ltd.;"},{"key":"2019041121510001500_R40","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0022-3476(05)81720-2","article-title":"Local reactions to depot leuprolide therapy for central precocious puberty.","volume":"123","author":"Manasco","year":"1993","journal-title":"J Pediatr"},{"issue":"Suppl 1","key":"2019041121510001500_R41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000282864","article-title":"Clinical study results of the new formulation leuprorelin acetate three-month depot for the treatment of advanced prostate carcinoma","volume":"56","author":"Fornara","year":"1996","journal-title":"Urol Int"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/87\/9\/4111\/10401989\/jcem4111.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T07:40:48Z","timestamp":1555054848000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/87\/9\/4111\/2846460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9,1]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2002,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2001-020243","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9,1]]}}}